Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | GRIK1 | P39086 | 8/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 6/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.42 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.42 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.42 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.42 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.42 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.42 |
| ▸ | GRM8 | O00222 | 1/20 | 0.42 |
| ▸ | GRM6 | O15303 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9452863 | 0.89 | ALOX15 (0.48) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL2443865 | 0.88 | KMT2A (0.68) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL693114 | 0.88 | GRIK1 (0.44) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL9817851 | 0.88 | GRIK1 (0.44) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL27574890 | 0.86 | SLC1A1 (0.42) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL16054489 | 0.86 | ALOX15 (0.43) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL6239265 | 0.84 | GRIK1 (0.41) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL17559225 | 0.82 | ALOX15 (0.42) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL352342 | 0.82 | ALOX15 (0.52) | ALOX15BLMPMP22KMT2AGRIK1 | |
| SCHEMBL28571398 | 0.82 | ALOX15 (0.52) | ALOX15BLMPMP22KMT2AGRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190241607-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF BETA N METHYLAMINO L ALANINE IN CU ZN SUPEROXIDE DISMUTASE 1 | UNIV NORTH CAROLINA STATE (US) | 2019-08-08 | — | — | US | disclosed |
| EP-3102611-A1 | HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF | Cangene Corporation (CA) | 2016-12-14 | — | — | EP | disclosed |
| WO-2015113169-A1 | HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF | CNJ HOLDINGS, INC. (CA) | 2015-08-06 | — | — | WO | disclosed |
| CN-101374942-A | Method for purifying stem cell, embryonic cardiomyocyte and putative cardiomyocyte | ASUBIO PHARMA CO LTD (JP) | 2009-02-25 | — | — | CN | disclosed |
| EP-0514509-B1 | COMPOSITION AND ITS PREPARATION PROCESS USING ANTIGEN CONJUGATED TO ENZYMATIC ACTIVITY FOR IMMUNOLOGICAL DIAGNOSIS AND CHAGAS' DISEASE IMMUNOLOGICAL DIAGNOSIS KITS, FOR INDIVIDUAL AND EPIDEMIOLOGICAL APPLICATION, BASED ON THAT COMPOSITION | FUNDACAO OSWALDO CRUZ (BR) | 2000-09-20 | — | — | EP | disclosed |
| WO-2000001720-A2 | COMPOSITIONS AND METHODS FOR TREATING PAPILLOMAVIRUS-INFECTED CELLS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-01-13 | — | — | WO | disclosed |
| EP-0557406-A4 | -G(G)-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS | — | 1993-10-06 | — | — | EP | disclosed |
| EP-0557406-A1 | GAMMA-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241607-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF BETA N METHYLAMINO L ALANINE IN CU ZN SUPEROXIDE DISMUTASE 1 | SOD1, SOD3, BCAT1 | ALOX15 653/4885BLM 1280/4885PMP22 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.